About PL BioScience
PL BioScience is a company based in Aachen (Germany) founded in 2015. PL BioScience has raised $13.03 million across 2 funding rounds from investors including Lepure Biotech, AVANT BIO and b.value. PL BioScience offers products and services including ELAREM™ Prime, ELAREM™ Perform, ELAREM™ Ultimate, and ELAREM™ Matrix Kit. PL BioScience operates in a competitive market with competitors including Abcam, Stem Cell Technologies, BioLife Solutions, RoosterBio and Shanghai Doning Biotechnology, among others.
- Headquarter Aachen, Germany
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Pl Bioscience Gmbh
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$13.03 M (USD)
in 2 rounds
-
Latest Funding Round
$8.51 M (USD), Series A
Aug 11, 2024
-
Investors
Lepure Biotech
& 7 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of PL BioScience
PL BioScience offers a comprehensive portfolio of products and services, including ELAREM™ Prime, ELAREM™ Perform, ELAREM™ Ultimate, and ELAREM™ Matrix Kit.
Animal-free substitute for Fetal Bovine Serum in academic research
Supports pre-clinical stem cell expansion with enhanced growth factors
Virus-inactivated option for therapeutic applications in cell therapy
Hydrogel for 3D cultivation and isolation of mesenchymal stem cells
Funding Insights of PL BioScience
PL BioScience has successfully raised a total of $13.03M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $8.51 million completed in August 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in PL BioScience
PL BioScience has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Lepure Biotech, AVANT BIO and b.value.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment is made by AVANT BIO in life sciences technologies.
|
Locked | Locked | Locked | |
|
DeepTech startups are financed and supported by b.value AG.
|
Locked | Locked | Locked | |
|
Micro-venture capital firm investing in pre-seed to seed stage startups
|
Locked | Locked | Locked |
Investor details for PL BioScience
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by PL BioScience
Investment portfolio details for PL BioScience
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - PL BioScience
Detailed financials for PL BioScience
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Pl Bioscience Comparisons
Peer comparison for PL BioScience
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of PL BioScience
PL BioScience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Stem Cell Technologies, BioLife Solutions, RoosterBio and Shanghai Doning Biotechnology, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Biological reagents and antibodies are developed for life science research.
|
|
| Locked | Locked | Locked |
Developer of cell culture media and ancillary reagents for life science research
|
|
| Locked | Locked | Locked |
Tissue hypothermic storage and cryopreservation freeze media are developed.
|
|
| Locked | Locked | Locked |
Developer of human mesenchymal stem cells and extracellular vesicles
|
|
| Locked | Locked | Locked |
Serum-free cell culture media is supplied to biopharmaceutical industries.
|
|
| Locked | Locked | Locked |
Transfection Solutions for Healthcare and Life Sciences organizations
|
Detailed competitors of PL BioScience
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pl Bioscience
Complete news archive for PL BioScience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PL BioScience
PL BioScience was founded in 2015 and raised its 1st funding round 6 years after it was founded.
PL BioScience is headquartered in Aachen, Germany. It is registered at Aachen, North Rhine-westphalia, Germany.
Hatim Hemeda is the current CEO of PL BioScience.
PL BioScience is a funded company, having raised a total of $13.03M across 2 funding rounds to date.
PL BioScience was founded in 2015 in Aachen, Germany, within the biotechnology sector. Cell culture products, including platelet lysate and xeno-free media, are developed for stem cell expansion in research and clinical settings. A 3D cell culture system enriched with platelet-derived growth factors is also offered to support cellular therapeutics development and implementation. Operations focus on solutions for both research and clinical applications.
PL BioScience's top competitors include Abcam, RoosterBio and BioLife Solutions.
PL BioScience offers ELAREM™ Prime, ELAREM™ Perform, ELAREM™ Ultimate, and ELAREM™ Matrix Kit.
PL BioScience has 8 investors. Key investors include Lepure Biotech, AVANT BIO, b.value, Better Ventures, and Brightlands Venture Partners.